US$ 21.15
small molecule glp-1 agonist BioWorld Figure 1 from Small Molecule
Description
Nature Commun

Patients are advised to check pricing at multiple locations and review their provincial drug benefit eligibility before filling prescriptions

It demonstrated to have a safety profile similar to GLP-1RA not increasing the risk of hypoglycemia (48)

GLP-1s for Osteoarthritis GLP-1 drugs may slow the progression of osteoarthritis, as research has found that people on the drugs lost more weight and had fewer knee surgeries than people not taking a GLP-1

Hansen HH

1 Given the differences within the drug class, switching from one GLP1RA to another may be beneficial and may delay the need to intensify therapy, thus avoiding an increase in treatment burden
